|
0 Companies |
|
0 Products |
|
0 Products |
|
4 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- Trial primary completion date: UVA1 Light for Scleroderma and Similar Conditions (clinicaltrials.gov) - Aug 14, 2015
P=N/A, N=23, Terminated, Sponsor: University of Michigan
Trial primary completion date: May 2011 --> Jul 2003
- Enrollment change: Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix (clinicaltrials.gov) - May 1, 2015
P1/2, N=33, Completed, Sponsor: University of Michigan
Trial primary completion date: May 2011 --> Jul 2003 N=50 --> 33
- | Trial completion: Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix (clinicaltrials.gov) - Apr 29, 2015
P1/2, N=33, Completed, Sponsor: University of Michigan
N=50 --> 33 Recruiting --> Completed
- Enrollment change: UVA1 Light for Scleroderma and Similar Conditions (clinicaltrials.gov) - Feb 11, 2015
P=N/A, N=23, Terminated, Sponsor: University of Michigan
Recruiting --> Completed N=50 --> 23
- Trial termination: UVA1 Light for Scleroderma and Similar Conditions (clinicaltrials.gov) - Oct 2, 2011
P=N/A, N=50, Terminated, Sponsor: University of Michigan
N=50 --> 23 Active, not recruiting --> Terminated; inactivity